Sign Up to like & get
recommendations!
0
Published in 2020 at "Analytical Methods"
DOI: 10.1039/d0ay00471e
Abstract: Febuxostat (FEB) is a selective xanthine oxidase (XO) inhibitor approved for chronic management of hyperuricemia (HU) in patients with gout. Non-steroidal anti-inflammatory drugs (NSAIDs) such as diclofenac (DIC) are the first choice for the prevention…
read more here.
Keywords:
method simultaneously;
feb dic;
method;
feb ... See more keywords